Equities

Devyser Diagnostics AB

Devyser Diagnostics AB

Actions
  • Price (EUR)11.20
  • Today's Change-0.65 / -5.49%
  • Shares traded0.00
  • 1 Year change+123.11%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments263364378
Total Receivables, Net453326
Total Inventory21106.73
Prepaid expenses135.082.12
Other current assets, total--0.000.00
Total current assets342412413
Property, plant & equipment, net923117
Goodwill, net6.706.770.24
Intangibles, net493318
Long term investments--02.06
Note receivable - long term0.100.09--
Other long term assets----0.00
Total assets510501457
LIABILITIES
Accounts payable149.609.66
Accrued expenses202113
Notes payable/short-term debt000
Current portion long-term debt/capital leases185.523.00
Other current liabilities, total11163.88
Total current liabilities635129
Total long term debt57169.96
Total debt752113
Deferred income tax0.200.33--
Minority interest------
Other liabilities, total4.601.950.80
Total liabilities1256940
SHAREHOLDERS EQUITY
Common stock0.900.930.87
Additional paid-in capital513508449
Retained earnings (accumulated deficit)(130)(78)(33)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total1.200.84(0.44)
Total equity385431417
Total liabilities & shareholders' equity510501457
Total common shares outstanding161615
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.